| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Adverum Biotechnologies, Inc.
13G
ADVM · 00773U207
|
5.1% |
12/17/2024
Event 12/17/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.